DR5/Ligase 3反馈环路维持错配修复缺陷结直肠癌的免疫原性
该研究探讨错配修复缺陷(dMMR)/微卫星不稳定(MSI)结直肠癌免疫原性的机制。利用同系肿瘤模型、免疫细胞共培养及类器官气液界面培养,发现Mlh1失活引起内质网应激和DR5介导的凋亡,核Ligase 3释放染色体外环状DNA维持免疫反应,DR5/Lig3反馈环路放大凋亡与免疫激活,且DR5或LIG3表达与患者ICI疗效相关。
要点
- Mlh1失活通过内质网应激和DR5介导凋亡引发抗肿瘤免疫。
- 核Ligase 3释放染色体外环状DNA是维持免疫应答所必需。
- DR5/Lig3反馈环路增强凋亡与免疫激活,影响ICI疗效。
核心结论
- dMMR与抗肿瘤免疫之间存在功能性联系,DR5/Lig3反馈环路维持免疫原性。
研究设计与样本
- 采用同系移植肿瘤模型、免疫细胞共培养实验及肿瘤来源类器官气液界面培养。
- 分析接受ICI治疗的结直肠癌患者基因表达数据库。
主要发现
- Mlh1失活导致同系结直肠肿瘤内质网应激和DR5介导的凋亡。
- 针对Mlh1缺陷肿瘤的持续免疫应答需要核Ligase 3介导的凋亡细胞染色体外环状DNA释放。
- DR5/Lig3反馈放大环路维持Mlh1缺陷同系肿瘤的凋亡和免疫细胞激活。
- 该反馈机制对小鼠ICI治疗反应至关重要。
- DR5或LIG3表达与癌症患者ICI治疗疗效显著相关。
临床怎么用
- DR5或LIG3表达可能作为ICI治疗疗效的参考标志物。
- 靶向DR5/Lig3反馈环路或可改善不同MMR状态肿瘤的ICI治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Colorectal cancers (CRCs) with deficient DNA mismatch repair (dMMR) and microsatellite instability (MSI) are believed to be intrinsically immunogenic and respond more favorably to immune checkpoint inhibitor (ICI) therapy. However, a significant fraction of dMMR/MSI CRCs do not respond or eventually develop resistance to ICIs. The mechanisms underlying dMMR/MSI-associated immunogenicity is unclear. The aim of this study was to investigate the role and mechanism of MSI-induced antitumor immunity in CRCs. METHODS: We used transplant syngeneic tumor models, immune cell coculture assays, and air-liquid interface culture of tumor-derived organoids to investigate the mechanism by which dMMR elicits an antitumor immune response. We also analyzed the gene expression databases of CRC cancer patients receiving ICI treatment. RESULTS: We found that inactivating Mlh1 causes endoplasmic reticulum stress and death receptor 5 (Dr5)-mediated apoptosis in syngeneic colorectal tumors. Sustained immune response against Mlh1-deficient tumors requires nuclear Ligase 3 (Lig3)-mediated release of extrachromosomal circular DNAs from apoptotic cells. A feedback Dr5/Lig3 amplification loop perpetuates apoptosis and immune cell activation in Mlh1-deficient syngeneic tumors. This feedback mechanism is critical for the response to ICI therapy in mice, which is supported by a significant association between DR5 or LIG3 expression and the efficacy of ICI therapy in cancer patients. CONCLUSIONS: Our results reveal a functional link between dMMR and antitumor immunity, which may be useful for improving ICI therapy in tumors with different MMR statuses.
引用
- Hao S, Sato Y, Battaglin F, et al. A DR5/Ligase 3-Mediated Feedback Loop Perpetuates Immunogenicity in Mismatch Repair Deficient Colorectal Cancer. Gastroenterology. 2026. PMID: 42462829. doi:10.1053/j.gastro.2026.06.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。